Gene · 9869
Papers2,616
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 2,616
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Status and Prospects of Epigenetics in the Treatment of Lymphoma. | Front Oncol | 2022 | 35463343 | PubTator, text mining | PubMed |
| Targeting Cancer Stem Cells through Epigenetic Modulation of Interferon Response. | J Pers Med | 2022 | 35455671 | PubTator, text mining | PubMed |
| The Impact of Genetic Polymorphisms in Glutamate-Cysteine Ligase, a Key Enzyme of Glutathione Biosynthesis, on Ischemic Stroke Risk and Brain Infarct Size. | Life (Basel) | 2022 | 35455093 | PubTator, text mining | PubMed |
| HIV-1-Mediated Acceleration of Oncovirus-Related Non-AIDS-Defining Cancers. | Biomedicines | 2022 | 35453518 | PubTator, text mining | PubMed |
| Epigenetic modification regulates tumor progression and metastasis through EMT (Review). | Int J Oncol | 2022 | 35445731 | PubTator, text mining | PubMed |
| Maintaining Transcriptional Specificity Through Mitosis. | Annu Rev Genomics Hum Genet | 2022 | 35440147 | PubTator, text mining | PubMed |
| A Whole-Genome CRISPR Screen Identifies AHR Loss as a Mechanism of Resistance to a PARP7 Inhibitor. | Mol Cancer Ther | 2022 | 35439318 | PubTator, text mining | PubMed |
| A Comprehensive Analysis of METTL1 to Immunity and Stemness in Pan-Cancer. | Front Immunol | 2022 | 35432338 | PubTator, text mining | PubMed |
| Author Correction: SETDB1-like MET-2 promotes transcriptional silencing and development independently of its H3K9me-associated catalytic activity. | Nat Struct Mol Biol | 2022 | 35428846 | PubTator, text mining | PubMed |
| Beyond the marks: reader-effectors as drivers of epigenetics and chromatin engineering. | Trends Biochem Sci | 2022 | 35427480 | PubTator, text mining | PubMed |
| In silico prediction and interaction of resveratrol on methyl-CpG binding proteins by molecular docking and MD simulations study. | RSC Adv | 2022 | 35425086 | PubTator, text mining | PubMed |
| High Risk-Human Papillomavirus in HNSCC: Present and Future Challenges for Epigenetic Therapies. | Int J Mol Sci | 2022 | 35408843 | PubTator, text mining | PubMed |
| Enhancer RNA Transcription Is Essential for a Novel CSF1 Enhancer in Triple-Negative Breast Cancer. | Cancers (Basel) | 2022 | 35406623 | PubTator, text mining | PubMed |
| The Emerging Role of E3 Ubiquitin Ligase SMURF2 in the Regulation of Transcriptional Co-Repressor KAP1 in Untransformed and Cancer Cells and Tissues. | Cancers (Basel) | 2022 | 35406379 | PubTator, text mining | PubMed |
| One genome, many cell states: epigenetic control of innate immunity. | Curr Opin Immunol | 2022 | 35405493 | PubTator, text mining | PubMed |
| SETDB1 interactions with PELP1 contributes to breast cancer endocrine therapy resistance. | Breast Cancer Res | 2022 | 35395812 | PubTator, text mining | PubMed |
| Regulation of Glucose, Fatty Acid and Amino Acid Metabolism by Ubiquitination and SUMOylation for Cancer Progression. | Front Cell Dev Biol | 2022 | 35392171 | PubTator, text mining | PubMed |
| scTEM-seq: Single-cell analysis of transposable element methylation to link global epigenetic heterogeneity with transcriptional programs. | Sci Rep | 2022 | 35388081 | PubTator, text mining | PubMed |
| Epigenetic cell memory: The gene's inner chromatin modification circuit. | PLoS Comput Biol | 2022 | 35385468 | PubTator, text mining | PubMed |
| Increased Expression of SETDB1 Predicts Poor Prognosis in Multiple Myeloma. | Biomed Res Int | 2022 | 35372573 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9869/papers?page=36